• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

藻酸盐-抗酸剂配方定位于酸性口袋,以减少胃食管反流病患者的胃酸反流。

An alginate-antacid formulation localizes to the acid pocket to reduce acid reflux in patients with gastroesophageal reflux disease.

机构信息

Department of Gastroenterology and Hepatology, Academic Medical Centre, Amsterdam, the Netherlands.

出版信息

Clin Gastroenterol Hepatol. 2013 Dec;11(12):1585-91; quiz e90. doi: 10.1016/j.cgh.2013.04.046. Epub 2013 May 10.

DOI:10.1016/j.cgh.2013.04.046
PMID:23669304
Abstract

BACKGROUND & AIMS: Alginate rafts (polysaccharide polymers that precipitate into a low-density viscous gel when they contact gastric acid) have been reported to form at the acid pocket, an unbuffered pool of acid that floats on top of ingested food and causes postprandial acid reflux. We studied the location of an alginate formulation in relation to the acid pocket and the corresponding effects on reflux parameters and acid pocket positioning in patients with gastroesophageal reflux disease (GERD).

METHODS

We randomly assigned patients with symptomatic GERD and large hiatal hernias to groups who were given either (111)In-labeled alginate-antacid (n = 8, Gaviscon Double Action Liquid) or antacid (n = 8, Antagel) after a standard meal. The relative positions of labeled alginate and acid pocket were analyzed for 2 hours by using scintigraphy; reflux episodes were detected by using high-resolution manometry and pH-impedance monitoring.

RESULTS

The alginate-antacid label localized to the acid pocket. The number of acid reflux episodes was significantly reduced in patients receiving alginate-antacid (3.5; range, 0-6.5; P = .03) compared with those receiving antacid (15; range, 5-20), whereas time to acid reflux was significantly increased in patients receiving alginate-antacid (63 minutes; range, 23-92) vs those receiving antacid (14 minutes; range, 9-23; P = .01). The acid pocket was located below the diaphragm in 71% of patients given alginate-antacid vs 21% of those given antacid (P = .08). There was an inverse correlation between a subdiaphragm position of the acid pocket and acid reflux (r = -0.76, P < .001).

CONCLUSIONS

In a study of 16 patients with GERD, we observed that the alginate-antacid raft localizes to the postprandial acid pocket and displaces it below the diaphragm to reduce postprandial acid reflux. These findings indicate the importance of the acid pocket in GERD pathogenesis and establish alginate-antacid as an appropriate therapy for postprandial acid reflux.

摘要

背景与目的

藻酸盐筏(接触胃酸时会沉淀成低密度粘性凝胶的多糖聚合物)据报道会在酸性口袋中形成,酸性口袋是一种未缓冲的胃酸池,漂浮在摄入的食物之上,导致餐后酸反流。我们研究了藻酸盐制剂在酸性口袋中的位置及其对胃食管反流病(GERD)患者反流参数和酸性口袋定位的相应影响。

方法

我们将有症状的 GERD 和大裂孔疝的患者随机分为两组,分别给予(111)In 标记的藻酸盐-抗酸剂(n = 8,Gaviscon Double Action Liquid)或抗酸剂(n = 8,Antagel),在标准餐后进行。通过闪烁扫描术分析标记藻酸盐和酸性口袋的相对位置 2 小时;通过高分辨率测压和 pH 阻抗监测检测反流事件。

结果

藻酸盐-抗酸剂标签定位于酸性口袋。与接受抗酸剂的患者(15;范围,5-20)相比,接受藻酸盐-抗酸剂的患者的酸反流次数明显减少(3.5;范围,0-6.5;P =.03),而接受藻酸盐-抗酸剂的患者的酸反流时间明显延长(63 分钟;范围,23-92)与接受抗酸剂的患者(14 分钟;范围,9-23;P =.01)。在接受藻酸盐-抗酸剂的患者中,71%的酸性口袋位于膈肌下方,而接受抗酸剂的患者中仅为 21%(P =.08)。酸性口袋位于膈肌下方的位置与酸反流呈负相关(r = -0.76,P <.001)。

结论

在 16 例 GERD 患者的研究中,我们观察到藻酸盐-抗酸剂筏定位于餐后酸性口袋,并将其推至膈肌下方,以减少餐后酸反流。这些发现表明酸性口袋在 GERD 发病机制中的重要性,并确立藻酸盐-抗酸剂是治疗餐后酸反流的合适疗法。

相似文献

1
An alginate-antacid formulation localizes to the acid pocket to reduce acid reflux in patients with gastroesophageal reflux disease.藻酸盐-抗酸剂配方定位于酸性口袋,以减少胃食管反流病患者的胃酸反流。
Clin Gastroenterol Hepatol. 2013 Dec;11(12):1585-91; quiz e90. doi: 10.1016/j.cgh.2013.04.046. Epub 2013 May 10.
2
An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial 'acid pocket' in symptomatic GERD patients.藻酸盐-抗酸剂配方(善卫宁双效液体)可消除或置换有症状的 GERD 患者餐后的“酸口袋”。
Aliment Pharmacol Ther. 2011 Jul;34(1):59-66. doi: 10.1111/j.1365-2036.2011.04678.x. Epub 2011 May 3.
3
Post-prandial reflux suppression by a raft-forming alginate (Gaviscon Advance) compared to a simple antacid documented by magnetic resonance imaging and pH-impedance monitoring: mechanistic assessment in healthy volunteers and randomised, controlled, double-blind study in reflux patients.餐后胃食管反流的抑制作用:基于磁共振成像和 pH 阻抗监测的藻酸盐(善卫喜 Advance)与简单抗酸剂的比较:健康志愿者的机制评估和反流患者的随机、对照、双盲研究
Aliment Pharmacol Ther. 2013 Jun;37(11):1093-102. doi: 10.1111/apt.12318. Epub 2013 Apr 18.
4
Alginate antacid (Gaviscon DA) chewable tablets reduce esophageal acid exposure in Chinese patients with gastroesophageal reflux disease and heartburn symptoms.藻酸盐抗酸剂(加胃斯康DA)咀嚼片可减少患有胃食管反流病和烧心症状的中国患者的食管酸暴露。
J Dig Dis. 2016 Nov;17(11):725-734. doi: 10.1111/1751-2980.12406.
5
Gaviscon Double Action Liquid (antacid & alginate) is more effective than antacid in controlling post-prandial oesophageal acid exposure in GERD patients: a double-blind crossover study.胃仙-U双重作用液(抗酸剂和藻酸盐)在控制胃食管反流病(GERD)患者餐后食管酸暴露方面比抗酸剂更有效:一项双盲交叉研究。
Aliment Pharmacol Ther. 2014 Sep;40(5):531-7. doi: 10.1111/apt.12857. Epub 2014 Jul 10.
6
Alginate-antacid combinations: raft formation and gastric retention studies.藻酸盐-抗酸剂组合:筏形成和胃滞留研究。
Drug Dev Ind Pharm. 2010 May;36(5):614-23. doi: 10.3109/03639040903388290.
7
Proton pump inhibitors reduce the size and acidity of the acid pocket in the stomach.质子泵抑制剂可减少胃内酸口袋的大小和酸度。
Clin Gastroenterol Hepatol. 2014 Jul;12(7):1101-1107.e1. doi: 10.1016/j.cgh.2014.04.003. Epub 2014 Apr 12.
8
[The acid pocket as the pathogenic basis and therapeutic target in gastroesophageal reflux disease].[酸袋作为胃食管反流病的致病基础和治疗靶点]
Ter Arkh. 2014;86(2):76-81.
9
Capping the gastric acid pocket to reduce postprandial acid gastroesophageal reflux.封堵胃酸袋以减少餐后胃酸性胃食管反流。
Clin Gastroenterol Hepatol. 2013 Dec;11(12):1592-4. doi: 10.1016/j.cgh.2013.06.008. Epub 2013 Jun 28.
10
Randomised clinical trial: the effectiveness of Gaviscon Advance vs non-alginate antacid in suppression of acid pocket and post-prandial reflux in obese individuals after late-night supper.随机临床试验:晚饭后,在肥胖个体中,Gaviscon Advance 与非藻酸盐抗酸剂抑制酸袋和餐后反流的效果比较。
Aliment Pharmacol Ther. 2020 Jun;51(11):1014-1021. doi: 10.1111/apt.15746. Epub 2020 Apr 28.

引用本文的文献

1
Review Article: Individualised Management of Reflux-Like Symptoms-Strategies Beyond Acid Suppression.综述文章:胃食管反流样症状的个体化管理——抑酸以外的策略
Aliment Pharmacol Ther. 2025 May;61(9):1437-1446. doi: 10.1111/apt.70115. Epub 2025 Apr 1.
2
Pathogenesis of pepsin-induced gastroesophageal reflux disease with advanced diagnostic tools and therapeutic implications.胃蛋白酶诱导的胃食管反流病的发病机制及先进诊断工具与治疗意义
Front Med (Lausanne). 2025 Feb 19;12:1516335. doi: 10.3389/fmed.2025.1516335. eCollection 2025.
3
Trial of alginates in throat symptoms: protocol for a pragmatic, multicentre, placebo controlled, double blind, parallel, randomised controlled trial of liquid alginate (Gaviscon Advance) for the treatment of persistent throat symptoms.
藻酸盐治疗咽喉症状的试验:一项实用、多中心、安慰剂对照、双盲、平行、随机对照试验的方案,该试验旨在研究液体藻酸盐(Gaviscon Advance)治疗持续性咽喉症状的效果。
BMJ Open. 2025 Jan 8;15(1):e087729. doi: 10.1136/bmjopen-2024-087729.
4
Unveiling the intricacies: Insight into gastroesophageal reflux disease.揭示复杂性:深入了解胃食管反流病。
World J Gastroenterol. 2025 Jan 7;31(1):98479. doi: 10.3748/wjg.v31.i1.98479.
5
Update Motility Disorders: Gastro-Oesophageal Reflux Disease - Diagnostic and Conservative Approach.动力障碍性疾病的最新进展:胃食管反流病——诊断与保守治疗方法
Visc Med. 2024 Dec;40(6):299-309. doi: 10.1159/000541358. Epub 2024 Oct 18.
6
Global Transcriptomic Analysis of Topical Sodium Alginate Protection against Peptic Damage in an In Vitro Model of Treatment-Resistant Gastroesophageal Reflux Disease.局部应用海藻酸钠预防难治性胃食管反流病的体外模型中消化性损伤的全球转录组分析。
Int J Mol Sci. 2024 Oct 5;25(19):10714. doi: 10.3390/ijms251910714.
7
Topical Alginate Protection against Pepsin-Mediated Esophageal Damage: E-Cadherin Proteolysis and Matrix Metalloproteinase Induction.藻酸盐局部保护对抗胃蛋白酶介导的食管损伤:E-钙黏蛋白的蛋白水解和基质金属蛋白酶诱导。
Int J Mol Sci. 2023 Apr 27;24(9):7932. doi: 10.3390/ijms24097932.
8
Randomised clinical trial: the use of alginates during preinvestigation proton pump inhibitor wash-out and their impact on compliance and symptom burden.随机临床试验:质子泵抑制剂洗脱前使用藻酸盐及其对依从性和症状负担的影响。
BMJ Open Gastroenterol. 2023 Jan;10(1). doi: 10.1136/bmjgast-2022-001026.
9
Current advances in the diagnosis and management of gastroesophageal reflux disease.胃食管反流病诊断与管理的当前进展
Tzu Chi Med J. 2022 May 16;34(4):402-408. doi: 10.4103/tcmj.tcmj_323_21. eCollection 2022 Oct-Dec.
10
Natural Biopolymers as Additional Tools for Cell Microencapsulation Applied to Cellular Therapy.天然生物聚合物作为细胞微囊化的附加工具应用于细胞治疗。
Polymers (Basel). 2022 Jun 29;14(13):2641. doi: 10.3390/polym14132641.